BRENNA PAYNE: Open Payments
NPI 1013294495 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 17 payments from 9 companies in 2025. Trend: 2023 $468 · 2024 $351 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Astellas Pharma US Inc | 4 | $85 |
| Acella Pharmaceuticals, LLC | 2 | $36 |
| Organon LLC | 2 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| Medtronic, Inc. | 1 | $15 |
Products named: Veozah, MYFEMBREE, GEMTESA, NP Thyroid 60, NEXPLANON, JOURNAVX, INJECTAFER, Exparel.
Industry payments across TX — which companies pay providers there.
